Incyte
INCY
#970
Rank
โ‚น2.472 T
Marketcap
โ‚น12,196
Share price
-0.36%
Change (1 day)
65.63%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2026 (TTM): โ‚น650.47

According to Incyte's latest financial reports the company's current EPS (TTM) is โ‚น697.37. In 2025 the company made an earnings per share (EPS) of โ‚น630.50 an increase over its 2024 EPS that were of โ‚น29.61.

EPS history for Incyte from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น650.473.17%
2025โ‚น630.502029.03%
2024โ‚น29.61-88.39%
2023โ‚น255.0773.38%
2022โ‚น147.12-64.1%
2021โ‚น409.82-408.63%
2020-โ‚น132.79-166.83%
2019โ‚น198.70300%
2018โ‚น49.68-133.33%
2017-โ‚น149.03-378.57%
2016โ‚น53.502700%
2015โ‚น1.91-106.67%
2014-โ‚น28.66-44.44%
2013-โ‚น51.5950%
2012-โ‚น34.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
โ‚น670.62-3.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น125.14-82.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,696 286.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,383 98.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น748.96 7.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น10.51-101.51%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น55.41-107.95%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚น80.25-111.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚น21.97-103.15%๐Ÿ‡บ๐Ÿ‡ธ USA